Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

MET dysregulation promoting tumorigenesis in non-small cell lung cancer (NSCLC) is associated with worse outcomes following chemotherapy as compared to non-driver mutated NSCLC and occurs either through mutations causing MET exon 14 skipping (METex14) or gene amplification and overexpression that re...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Matthew Z, Marrone, Kristen A, Spira, Alexander, Waterhouse, David M, Scott, Susan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627896/
https://www.ncbi.nlm.nih.gov/pubmed/34853516
http://dx.doi.org/10.2147/OTT.S273357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627896/
https://www.ncbi.nlm.nih.gov/pubmed/34853516
http://dx.doi.org/10.2147/OTT.S273357

Ejemplares similares